Learn More
Medchemexpress LLC Malotilate | 59937-28-9 | 99.5% | C12H16O4S2 | 100 MG

Supplier: Medchemexpress LLC HYA0060100MG
Malotilate is an orally active hepatotropic agent and an anti-fibrotic substance. It selectively inhibits 5-lipoxygenase (5-LOX) with an IC50 of 4.7 μM. It prevents the development of hepatocytic injury in alcohol-pyrazole hepatitis by decreasing hepatic acetaldehyde levels and preventing the retention of transferrin in the hepatocytes. For research use only.
- Reduces collagen synthesis and cell migration activity of fibroblasts in vitro
- Stimulates 12- and 15-lipoxygenase pathways
- Prevents acute experimental liver injury induced by various hepatotoxic compounds
- Normalizes lowered serum cholesterol in rats with hypocholesterolemia
- Normalizes inhibition of triglyceride secretion from livers in rats with CCl4-induced liver damage
By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.